𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Discounting and health benefits: Another Perspective

✍ Scribed by John Cairns

Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
290 KB
Volume
1
Category
Article
ISSN
1057-9230

No coin nor oath required. For personal study only.

✦ Synopsis

This paper reviews the argument advanced by Parsonage and Neuburger that the non-monetary benefits of health programmes should be discounted at a lower rate than that used for financial flows. The conceptual issues raised in that paper are discussed and others, such as the tradability of non-monetary benefits and the link between individual and social discount rates, are introduced. The collection and assessment of more evidence is needed before Parsonage and Neuburger's proposition can be supported.

📜 SIMILAR VOLUMES

Discounting future health benefits: the
Discounting future health benefits: the poverty of consistency arguments
✍ Erik Nord 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

In economic evaluation of health care, main stream practice is to discount benefits at the same rate as costs. But main papers in which this practice is advocated have missed a distinction between two quite different evaluation problems: (1) How much does the time of program occurrence matter for va

Discounting for health effects in cost–b
Discounting for health effects in cost–benefit and cost-effectiveness analysis
✍ Hugh Gravelle; Dave Smith 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 1 views

## Abstract When health effects can be valued in monetary terms, as in cost–benefit analysis, they should be discounted at the same rate as costs. If health effects are measured in quantities (e.g. quality adjusted life years) as in cost‐effectiveness analysis (CEA) and the value of health effects

Aggregation rules for cost–benefit analy
Aggregation rules for cost–benefit analysis: a health economics perspective
✍ Josephine Borghi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 2 views

## Abstract Few willingness‐to‐pay (WTP) studies in the health sector have used their results within a cost–benefit analysis (CBA), an essential step to informing resource allocation decisions. This paper provides an overview of aggregation methods, reviews current evidence of practice in the healt

DISCOUNTING HEALTH AND COST-EFFECTIVENES
DISCOUNTING HEALTH AND COST-EFFECTIVENESS ANALYSIS: A RESPONSE TO NORD
✍ James K. Hammitt 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 1 views

## SUMMARY Nord (2011) criticizes standard arguments which assert that consistency requires that future health benefits must be discounted at the same rate as future costs in cost‐effectiveness analysis (CEA). He suggests these arguments are misguided because they require transitivity of preference

Fieller's method and net health benefits
Fieller's method and net health benefits
✍ Daniel F. Heitjan 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Statistical and conceptual difficulties complicate the estimation of the incremental cost-effectiveness ratio (ICER). An alternative approach is to measure cost-effectiveness by the incremental net health benefit (INHB), defined as the difference in mean effectiveness of a new treatment compared wit

Economic rate of discount and estimating
Economic rate of discount and estimating cost benefit of viral immunisation programmes
✍ R. R. West 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

Many individual and societal decisions over purchase (or investment) involve consideration of timing, in that either the price may be paid now and the benefit enjoyed some time in the future or the converse the benefit enjoyed now and the price paid later. Since most individuals generally prefer the